Evidence map›Paper›PMID 42269084›Full record

ArticleBlood advances2026

Brentuximab vedotin after alloSCT for relapsed/refractory Hodgkin lymphoma: GHSG BV-ALLO phase 2 trial.

Christof Scheid, Janina Jablonski, Andrea Kerkhoff, Matthias Stelljes, Karolin Trautmann-Grill, Martin Bornhäuser, Johanna M Tischer, Michael von Bergwelt-Baildon, Dietlinde Janson, Francis Ayuk and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Christof ScheidCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Janina JablonskiGerman Hodgkin Study Group, Cologne, Germany.ORCID 0009-0007-2811-4762
Andrea KerkhoffUniversity Hospital Münster, Münster, Germany.
Matthias StelljesUniversity Hospital Münster, Münster, Germany.
Karolin Trautmann-GrillUniversity Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Martin BornhäuserUniversity Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Johanna M TischerUniversity Hospital, Ludwig Maximilian University, Munich, Germany.
Michael von Bergwelt-BaildonUniversity Hospital, Ludwig Maximilian University, Munich, Germany.
Dietlinde JansonUniversity Hospital Eppendorf, Hamburg, Germany.
Francis AyukUniversity Hospital Eppendorf, Hamburg, Germany.
Nicolaus KrögerUniversity Hospital Eppendorf, Hamburg, Germany.ORCID 0000-0001-5103-9966
Udo HoltickCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Tim RichardsonCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0009-0006-3588-6376
Bastian von TresckowCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0003-1410-4487
Michael FuchsCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Peter BorchmannCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Paul J BröckelmannCenter for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0001-9662-9900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42269084
PMCPMC13486789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.